Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow‐on formula manufactured from hydrolysed protein by Danone Trading ELN B.V.

Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow‐on formula manufactured from hydrolysed protein by Danone Trading ELN B.V.

Abstract The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from whey protein concentrate and used in an infant and follow‐on formula by Danone Trading ELN B.V, which submitted a dossier to the European...

Full description

Bibliographic Details
Main Authors: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Jacqueline Castenmiller, Stefaan deHenauw, Karen‐Ildico Hirsch‐Ernst, John Kearney, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marco Vinceti, Jean‐Louis Bresson, Laurence Castle, Mary Fewtrell, Hildegard Przyrembel, Céline Dumas, Ariane Titz, Dominique Turck
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:EFSA Journal
Subjects:
Protein hydrolysate
characterisation
formula
nutritional safety
suitability
clinical trial
Online Access:https://doi.org/10.2903/j.efsa.2020.6304

Internet

https://doi.org/10.2903/j.efsa.2020.6304

Similar Items